Company / Accounts Receivable
Penumbra, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$190.0M
FY2025
5-year range
$133.9M / $203.4M
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
#73 of 138
Health Care
What the data says
At $190M, Penumbra, Inc.'s accounts receivable ranks #73 of 138 in the Health Care sector. Accounts Receivable returned to growth in FY2025 after 2 years of decline, reaching $190M.
Based on SEC 10-K filings.
$190M in FY2025 with a 5-year CAGR of +10.6%.
Declined from $202M to $190M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
#73 of 138 in Health CareTop 53% of 138This company $190.0M Sector average $1.3B
▼
-85.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, accounts receivable increased 13.3% year-over-year.
- Ranks #73 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $190.0M | +13.3% |
| FY2024 | $167.7M | -16.9% |
| FY2023 | $201.8M | -0.8% |
| FY2022 | $203.4M | +51.8% |
| FY2021 | $133.9M | +16.9% |
| FY2020 | $114.6M | +8.2% |
| FY2019 | $105.9M | +29.3% |
| FY2018 | $81.9M | +41.2% |
| FY2017 | $58.0M | +33.9% |
| FY2016 | $43.3M | +47.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026